Home › Funds › Artia Global Partners LP › ORKA
Artia Global Partners LP position in ORKA
ORUKA THERAPEUTICS INC · Health Care
Artia Global Partners LP reported holding 33,400 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.59% of its reported portfolio and ranking #37 among its reported holdings. Artia Global Partners LP has disclosed ORKA holdings in 2 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's ORKA position evolved
Artia Global Partners LP first disclosed a stake in ORKA in Q1 2025 at 7,380 shares (US$76K). The position peaked in Q2 2026 at 33,400 shares, worth US$3.2M. Across 2 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 33,400 shares valued at US$3.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 7.38K | $75.72K | New |
| Q2 2026 | 33.40K | $3.18M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORKA and 13F data
ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 99 other funds we track also report a position in ORKA — the largest reported positions include Venrock Adviser, LLC (US$394.8M), Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORKA
- Venrock Adviser, LLC 4.15M sh · $394.81M · Q2 2026
- Fairmount Funds Management LLC 3.71M sh · $352.63M · Q2 2026
- RTW INVESTMENTS, LP 3.14M sh · $298.74M · Q2 2026
- Paradigm Biocapital Advisors LP 2.14M sh · $204.09M · Q2 2026
- Deep Track Capital, LP 1.93M sh · $183.30M · Q2 2026
- Bellevue Group AG 1.66M sh · $157.71M · Q2 2026
- Remedium Capital Partners, LLC 1.57M sh · $149.00M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.55M sh · $147.95M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.35M sh · $128.01M · Q2 2026
- Avidity Partners Management LP 760.42K sh · $72.37M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 658.30K sh · $62.65M · Q2 2026
- Affinity Asset Advisors, LLC 590.00K sh · $56.15M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held ORKA?
Artia Global Partners LP has disclosed ORKA holdings in 2 of the last 6 reported quarters, going back to Q1 2025.
What is Artia Global Partners LP's current position in ORKA?
As of Q2 2026, Artia Global Partners LP holds 33.40K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $3.18M, representing 0.59% of its reported portfolio and ranking #37.
Has Artia Global Partners LP been buying or selling ORKA?
In the latest 13F filing (Q2 2026), Artia Global Partners LP newly opened its position in ORKA. The position peaked in Q2 2026 at 33.40K shares.
Which other funds hold ORKA?
Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 99 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.